Related Experiment Videos
Fenfluramine-induced place aversion in a three-choice apparatus
1Department of Psychology, Wilfrid Laurier University, Waterloo, Ontario, Canada.
Pharmacology, Biochemistry, and Behavior
|March 1, 1993
Summary
Fenfluramine, an appetite suppressant, was tested for its effects on rats. Higher doses of fenfluramine (2.5-10 mg/kg) resulted in rats avoiding the drug-associated environment, indicating aversion.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Anorectic agents are used for weight management.
- Understanding the behavioral effects of drugs is crucial for therapeutic development.
- Fenfluramine is a known anorectic agent with complex neurochemical actions.
Purpose of the Study:
- To evaluate the hedonic properties of fenfluramine.
- To determine if fenfluramine induces place preference or aversion in rats.
- To assess dose-dependent behavioral responses to fenfluramine.
Main Methods:
- Place conditioning paradigm used in rats.
- Four conditioning trials administered.
- Testing involved preference for drug-paired, saline-paired, and novel chambers.
Main Results:
- Fenfluramine was administered at various doses (0.25, 1.0, 2.5, 5.0, 10.0 mg/kg).
- A significant place aversion was observed at fenfluramine doses of 2.5-10 mg/kg.
- Lower doses (0.25, 1.0 mg/kg) did not produce a significant effect.
Conclusions:
- Fenfluramine exhibits aversive properties at moderate to high doses.
- These findings suggest potential limitations for fenfluramine's use due to negative hedonic impact.
- Further research is needed to explore the mechanisms underlying fenfluramine-induced aversion.